INNV
Price
$9.52
Change
+$0.38 (+4.16%)
Updated
Oct 22 closing price
Capitalization
1.3B
12 days until earnings call
Intraday BUY SELL Signals
USPH
Price
$88.86
Change
+$2.58 (+2.99%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.29B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INNV vs USPH

INNV vs USPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
INNV vs. USPH commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNV is a Buy and USPH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for INNV with price predictions
Oct 22, 2026

INNV's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for INNV turned positive on October 09, 2026. Looking at past instances where INNV's MACD turned positive, the stock continued to rise in 42 of 49 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INNV's RSI Indicator exited the oversold zone, 17 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on INNV as a result. In 90 of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where INNV advanced for three days, in 234 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 138 of 171 cases where INNV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INNV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

INNV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.514) is normal, around the industry mean (204.132). INNV's P/E Ratio (-476.000) is considerably lower than the industry average of (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (1.488) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. INNV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INNV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for USPH with price predictions
Oct 22, 2026

USPH in downward trend: price may drop because broke its higher Bollinger Band on October 22, 2026

USPH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 26 of the 35 cases the stock fell afterwards. This puts the odds of success at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for USPH moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on USPH as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for USPH just turned positive on October 22, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.

Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 217 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 159 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.870) is normal, around the industry mean (204.132). USPH's P/E Ratio (507.529) is considerably higher than the industry average of (18.957). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.021) settles around the average of (0.100) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

FUNDAMENTALS RATINGS
USPH: Fundamental Ratings
USPH
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INNVUSPH
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 11 days ago
66%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 1 day ago
63%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (INNV: $9.52 vs. USPH: $88.73)
Brand notoriety: INNV and USPH are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: INNV: 200% vs. USPH: 76%
Market capitalization -- INNV: $1.3B vs. USPH: $1.29B
INNV [@Hospital/Nursing Management] is valued at $1.3B. USPH’s [@Hospital/Nursing Management] market capitalization is $1.29B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $99.46B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNV’s FA Score shows that 1 FA rating(s) are green while USPH’s FA Score has 1 green FA rating(s).

  • INNV’s FA Score: 1 green, 4 red.
  • USPH’s FA Score: 1 green, 4 red.
According to our system of comparison, both INNV and USPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INNV’s TA Score shows that 5 TA indicator(s) are bullish while USPH’s TA Score has 4 bullish TA indicator(s).

  • INNV’s TA Score: 5 bullish, 3 bearish.
  • USPH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INNV is a better buy in the short-term than USPH.

Price Growth

INNV (@Hospital/Nursing Management) experienced а +6.01% price change this week, while USPH (@Hospital/Nursing Management) price change was +3.20% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.24%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +22.44%.

Reported Earning Dates

INNV is expected to report earnings on Nov 03, 2026.

USPH is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+1.24% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
INNV
Daily Signal:
Gain/Loss:
USPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

USPH and

Correlation & Price change

A.I.dvisor tells us that USPH and BTMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USPH and BTMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USPH
1D Price
Change %
USPH100%
+2.84%
BTMD - USPH
30%
Poorly correlated
+5.83%
OPCH - USPH
29%
Poorly correlated
N/A
ENSG - USPH
29%
Poorly correlated
+2.88%
THC - USPH
27%
Poorly correlated
+0.56%
INNV - USPH
25%
Poorly correlated
+4.16%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBOT2.850.17
+6.34%
BridgeBio Oncology Therapeutics Inc
CIGI96.463.71
+4.00%
Colliers International Group
MMI28.280.14
+0.50%
Marcus & Millichap
PCAR109.59-0.63
-0.57%
PACCAR
KYNB5.04-0.17
-3.26%
Kyntra Bio Inc